Daratumumab Injection Market: Transforming Multiple Myeloma...

toegevoegd een audio Health

2026-08-11 12:10:25 -

Daratumumab Injection Market: Transforming Multiple Myeloma Treatment with CD38-Targeted Immunotherapy

The global oncology landscape is witnessing a paradigm shift with the emergence of highly targeted immunotherapies, and at the forefront of this revolution is the Daratumumab Injection Market . Daratumumab, a first-in-class monoclonal antibody targeting CD38, has fundamentally transformed the treatment paradigm for multiple myeloma and other hematological malignancies. By binding to...

0 Reacties 0 aandelen 185 Views 0 voorbeeld